Polymorphism of the NFKB1 affects the serum inflammatory levels of IL-6 in Hashimoto thyroiditis in a Turkish population

Immunobiology

Volumn 219, Issue 7, 2014, Pages 531-536

  Koc, Arzuhan ^a   Batar, Bahadir ^a   Celik, Ozlem ^a   Onaran, Ilhan ^a   Tasan, Ertugrul ^a   Sultuybek, Gonul Kanigur ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

ELISA; Hashimoto thyroiditis; IL 6; NFKB1; NFKBIA; PCR RFLP; Polymorphism

Indexed keywords

INTERLEUKIN 6; THYROTROPIN; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NF-KAPPAB INHIBITOR ALPHA;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HASHIMOTO DISEASE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MIDDLE AGED; NFKB1 GENE; NFKBIA GENE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM; THYROTROPIN BLOOD LEVEL; TURKEY (REPUBLIC); ALLELE; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; INDEL MUTATION; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TURKEY;

ADULT; ALLELES; BASE SEQUENCE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE FREQUENCY; GENOTYPE; HASHIMOTO DISEASE; HUMANS; I-KAPPA B PROTEINS; INDEL MUTATION; INTERLEUKIN-6; MIDDLE AGED; NF-KAPPA B; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROMOTER REGIONS, GENETIC; TURKEY;

EID: 84900418487     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2014.03.009     Document Type: Article

References (49)

1. Baldwin A.S. The transcription factor NF-kB and human disease. J. Clin. Invest. 2001, 107(1):3-6.
2. Barbesino G., Chiovato L. The genetics of Hashimoto's disease. Endocrinol. Metab. Clin. North Am. 2000, 29(2):357-374.
3. Basolo F., Fiore L., Pollina L., Fontanini G., Conaldi P.G., Toniolo A. Reduced expression of interleukin 6 in undifferentiated thyroid carcinoma: in vitro and in vivo studies. Clin. Cancer Res. 1998, 4(2):381-387.
4. Borm M.E., van Bodegraven A.A., Mulder C.J., Kraal G., Bouma G. A NFKB1 promoter polymorphism is involved in susceptibility to ulcerative colitis. Int. J. Immunogenet. 2005, 32:401-405.
5. Chistiakov D.A. Immunogenetics of Hashimoto's thyroiditis. J. Autoimmun. Dis. 2005, 2:1.
6. Chun H.Y., Chung J.W., Kim H.A., Yun J.M., Jeon J.Y., Ye Y.M., Kim S.H., Park H.S., Suh C.H. Cytokine IL-6 and IL-10 as biomarkers in systemic lupus erythematosus. J. Clin. Immunol. 2007, 27(5):461-466.
7. Dultz G., Matheis N., Dittmar M., Röhrig B., Bender K., Kahaly G.J. The protein tyrosine phosphatase non-receptor Type 22 C1858T polymorphism is a joint susceptibility locus for immunthyroiditis and autoimmune diabetes. Thyroid 2009, 19(2):143-148.
8. Dupont W.D., Plummer W.D. PS power and sample size program available for free on the Internet. Control. Clin. Trials 1997, 18:274.
9. El-Shenawy S.Z., Hemi M.H., Attia H. Serum levels of proinflammatory cytokines (Interleukin 6 & Interleukin 15) and adiponectin in Hashimoto's Thyroiditis with different thyroid function states. J. Am. Sci. 2011, 7(6):1156-1162.
10. Galicia J.C., Tai H., Komatsu Y., Shimada Y., Akazawa K., Yoshie H. Polymorphisms in the IL-6 receptor (IL-6R) gene: strong evidence that serum levels of soluble IL-6R are genetically influenced. Genes Immun. 2004, 5(6):513-516.
11. Galimudi R.K., Spurthi M.K., Padala C., Kumar K.G., Mudigonda S., Reddy S.G., Aiyengar M.T., Sahu S.K., Rani S.H. Interleukin 6(-174G/C) variant and its circulating levels in coronary artery disease patients and their first degree relatives. Inflammation 2013, 10.1007/s10753-013-9742-8.
12. Gao M., Wang C.H., Sima X., Han X.M. NFKB1-94 insertion/deletion ATTG polymorphism contributes to risk of systemic lupus erythematosus. DNA Cell Biol. 2012, 31(4):611-615.
13. Ghosh S., Karin M. Missing pieces in the NF-kB puzzle. Cell 2002, 109:81-96.
14. Giachelia M., Voso M.T., Tisi M.C., Martini M., Bozzoli V., Massini G., D'Alo' F., Larocca L.M., Leone G., Hohaus S. Interleukin-6 plasma levels are modulated by a polymorphism in the NF-kB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma. Leuk. Lymphoma 2011, 00:1-6.
15. Glas J., Török H.P., Tonenchi L., Müller-Myhsok B., Mussack T., Wetzke M., Klein W., Epplen J.T., Griga T., Schiemann U., Lohse P., Seiderer J., Schnitzler F., Brand S., Ochsenkühn T., Folwaczny M., Folwaczny C. Role of the NFKB1-94ins/delATTG promoter polymorphism in IBD and potential interactions with polymorphisms in the CARD15/NOD2, IKBL, and IL-1RN genes. Inflamm. Bowel Dis. 2006, 12:606-611.
16. Goto Y., Yue L., Yokoi A., Nishimura R., Uehara T., Koizumi S., Saikawa Y. A novel single-nucleotide polymorphism in the 3'-untranslated region of the human dihydrofolate reductase gene with enhanced expression. Clin. Cancer Res. 2001, 7(7):1952-1956.
17. Hayden M.S., Ghosh S. Signaling to NF-kappaB. Genes Dev. 2004, 18(18):2195-2224.
18. Hirano T. Interleukin 6 in autoimmune and inflammatory diseases: a personal memoir. Proc. Jpn. Acad. Ser. B Phys. Biol. Sci. 2010, 86(7):717-730.
19. Hiromatsu Y., Satoh H., Amino N. Hashimoto's thyroiditis: history and future outlook. Hormones 2013, 12(1):12-18.
20. Hosokawa T., Kusugami K., Ina K., Ando T., Shinoda M., Imada A., Ohsuga M., Sakai T., Matsuura T., Ito K., Kaneshiro K. Interleukin-6 and soluble interleukin-6 receptor in the colonic mucosa of inflammatory bowel disease. J. Gastroenterol. Hepatol. 1999, 14:987-996.
21. Ishihara K., Hirano T. IL-6 in autoimmune disease and chronic inflammatory proliferative disease. Cytokine Growth Factor Rev. 2002, 13(4-5):357-368.
22. Karban A.S., Okazaki T., Panhuysen C.I., Gallegos T., Potter J.J., Bailey-Wilson J.E., Silverberg M.S., Duerr R.H., Cho J.H., Gregersen P.K., Wu Y., Achkar J.P., Dassopoulos T., Mezey E., Bayless T.M., Nouvet F.J., Brant S.R. Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis. Hum. Mol. Genet. 2004, 13(1):35-45.
23. Katarina K., Daniela P., Peter N., Marianna R., Pavlina C., Stepanka P., Jan L., Ludmila T., Michal A., Marie C. HLA, NFKB1 and NFKBIA gene polymorphism profile in autoimmune diabetes mellitus patients. Exp. Clin. Endocrinol. Diab. 2007, 115(2):124-129.
24. Klein W., Tromm A., Folwaczny C., Hagedorn M., Duerig N., Epplen J.T., Schmiegel W.H., Griga T. A polymorphism of the NFKBIA gene is associated with Crohn's disease patients lacking a predisposing allele of the CARD15 gene. Int. J. Colorectal. Dis. 2004, 19:153-156.
25. Kosoy R., Concannon P. Functional variants in SUMO4, TAB2, and NFkappaB and the risk of type 1 diabetes. Genes Immun. 2005, 6:231-235.
26. Kristiansen O.P., Mandrup-Poulsen T. Interleukin-6 and diabetes: the good, the bad, or the indifferent?. Diabetes 2005, 54(Suppl. 2).
27. Kurylowicz A., Hiromatsu Y., Jurecka-Lubieniecka B., Kula D., Kowalska M., Ichimura M., Koga H., Kaku H., Bar-Andziak E., Nauman J., Jarzab B., Ploski R., Bednarczuk T. Association of NFKB1-94ins/del ATTG promoter polymorphism with susceptibility to and phenotype of Graves' disease. Genes Immun. 2007, 8(7):532-538.
28. Lewander A., Butchi A.K., Gao J., He L.J., Lindblom A., Arbman G., Carstensen J., Zhang Z.Y., Sun X.F. Polymorphism in the promoter region of the NFKB1 gene increases the risk of sporadic colorectal cancer in Swedish but not in Chinese populations. Scand. J. Gastroenterol. 2007, 42(11):1332-1338.
29. López-Mejías R., García-Bermúdez M., González-Juanatey C., Castañeda S., Pérez-Esteban S., Miranda-Filloy J.A., Gómez-Vaquero C., Fernández-Gutiérrez B., Balsa A., Pascual-Salcedo D., Blanco R., González-Álvaro I., Llorca J., Martín J., González-Gay M.A. Lack of association between IL6 single nucleotide polymorphisms and cardiovascular disease in Spanish patients with rheumatoid arthritis. Atherosclerosis 2011, 219(2):655-658.
30. López-Mejías R., García-Bermúdez M., González-Juanatey C., Castañeda S., Miranda-Filloy J.A., Gómez-Vaquero C., Fernández-Gutiérrez B., Balsa A., Pascual-Salcedo D., Blanco R., González-Álvaro I., Llorca J., Martín J., González-Gay M.A. Lack of association of IL6R rs2228145 and IL6ST/gp130 rs2228044 gene polymorphisms with cardiovascular disease in patients with rheumatoid arthritis. Tissue Antigens 2011, 78(6):438-441.
31. López-Mejías R., García-Bermúdez M., González-Juanatey C., Castañeda S., Miranda-Filloy J.A., Gómez-Vaquero C., Fernández-Gutiérrez B., Balsa A., Pascual-Salcedo D., Blanco R., González-Álvaro I., Llorca J., Martín J., González-Gay M.A. NFKB1-94ATTG ins/del polymorphism (rs28362491) is associated with cardiovascular disease in patients with rheumatoid arthritis. Atherosclerosis 2012, 224(2):426-429.
32. Matsusaka T., Fujikawa K., Nishio Y., Mukaida N., Matsushima K., Kishimoto T., Akira S. Transcription factors NF-IL6 and NF-KB synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc. Natl. Acad. Sci. U. S. A. 1993, 90(21):10193-10197.
33. Mirza M.M., Fisher S.A., Onnie C., Lewis C.M., Mathew C.G., Sanderson J., Forbes A. No association of the NFKB1 promoter polymorphism with ulcerative colitis in a British case control cohort. Gut 2005, 54:1205-1206.
34. Neurath M.F., Finotto S. IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer. Cytokine Growth Factor Rev. 2011, 22(2):83-89.
35. Oliver J., Gomez-Garcia M., Paco L., Lopez-Nevot M.A., Pinero A., Correro F., Martin L., Brieva J.A., Nieto A., Martin J. A functional polymorphism of the NFKB1 promoter is not associated with ulcerative colitis in a Spanish population. Inflamm. Bowel Dis. 2005, 11:576-579.
36. Orozco G., Sanchez E., Collado M.D., Lopez-Nevot M.A., Paco L., Garcia A., Jimenez-Alonso J., Martin J. Analysis of the functional NFKB1 promoter polymorphism in rheumatoid arthritis and systemic lupus erythematosus. Tissue Antigens 2005, 65:183-186.
37. Papanicolaou D.A., Wilder R.L., Manolagas S.C., Chrousos G.P. The pathophysiologic roles of interleukin-6 in human disease. Ann. Intern. Med. 1998, 128(2):127-137.
38. Phenekos C., Vryonidou A., Gritzapis A.D., Baxevanis C.N., Goula M., Papamichail M. Th1 and Th2 serum cytokine profiles characterize patients with Hashimoto's thyroiditis (Th1) and Graves' disease (Th2). Neuroimmunomodulation 2004, 11(4):209-213.
39. Revez J.A., Bain L., Chapman B., Powell J.E., Jansen R., Duffy D.L., Tung J.Y., Collaborators A.A.G.C., Penninx P.M., Visscher P.M., De Geus E.J., Boomsma D.I., Hinds D.A., Martin N.G., Montgomery G.W., Ferreira M.A. A new regulatory variant in the interleukin-6 receptor gene associates with asthma risk. Genes Immun. 2013, 14(7):441-446. 10.1038/gene.2013.38.
40. Rogler G., Brand K., Vogl D., Page S., Hofmeister R., Andus T., Knuechel R., Baeuerle P.A., Schölmerich J., Gross V. Nuclear factor kappaB is activated in macrophages and epithelial cells of inflamed intestinal mucosa. Gastroenterology 1998, 115:357-369.
41. Romzova M., Hohenadel D., Kolostova K., Pinterova D., Fojtikova M., Ruzickova S., Dostal C., Bosak V., Rychlik I., Cerna M. NFκB and its inhibitor IκB in relation to Type 2 diabetes and its microvascular and atherosclerotic complications. Hum. Immunol. 2006, 67(9):706-713.
42. Rugerri R.M., Barresi G., Sciacchitano S. Immunoexpression of the CD30 Ligand/CD30 and IL-6/IL-6R signals in thyroid autoimmune diseases. Histol. Histopathol. 2006, 21:249-256.
43. Salvi M., Pedrazzoni M., Girasole G., Giuliani N., Minelli R., JR W., Roti E. Serum concentrations of proinflammatory cytokines in Graves' disease: effect of treatment, thyroid function, ophthalmopathy and cigarette smoking. Eur. J. Endocrinol. 2000, 143:197-202.
44. Sen A., Paine S.K., Chowdhury I.H., Mukherjee A., Choudhuri S., Saha A., Mandal L.K., Bhattacharya B. Impact of interleukin-6 promoter polymorphism and serum interleukin-6 level on the acute inflammation and neovascularization stages of patients with Eales' disease. Mol. Vis. 2011, 17:2552-2563.
45. Senol Tuncay S., Okyay P., Bardakci F. Identification of NF-KB1 and NF-KB1α polymorphisms Using PCR-RFLP Assay in a Turkish population. Biochem. Genet. 2010, 48:104-112.
46. Siemińska L., Wojciechowska C., Kos-Kudła B., Marek B., Kajdaniuk D., Nowak M., Głogowska-Szelag J., Foltyn W., Strzelczyk J. Serum concentrations of leptin, adiponectin, and interleukin-6 in postmenopausal women with Hashimoto's thyroiditis. Endokrynol. Pol. 2010, 61(1):112-116.
47. Song S., Chen D., Lu J., Liao J., Luo Y., Yang Z., Fu X., Fan X., Wei Y., Yang L., Wang L., Wang J. NFkB1 and NFkBIA polymorphisms are associated with increased risk for sporadic colorectal cancer in a southern Chinese population. PLoS ONE 2011, 6(6):1.
48. Tanaka T., Kishimoto T. Targeting interleukin-6: all the way to treat autoimmune and inflammatory diseases. Int. J. Biol. Sci. 2012, 8(9):1227-1236.
49. Zaletel K., Gaberšček S. Hashimoto's thyroiditis: from genes to the disease. Curr. Genomics 2011, 12(8):576-588.